Driehaus Capital Management LLC Nuvalent, Inc. Transaction History

Driehaus Capital Management LLC

$10.3 Billion
Q2 2025

A detailed history of Driehaus Capital Management LLC transactions in Nuvalent, Inc. stock. As of the latest transaction made, Driehaus Capital Management LLC holds 216,422 shares of NUVL stock, worth $18.1 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

216,422

Previous 531,210 59.26%

Holding current value

$18.1 Million

Previous $37.7 Million 56.17%

% of portfolio

0.16%

Previous 0.41%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$59.32 - $79.68 $18.7 Million - $25.1 Million	-314,788 Reduced 59.26%	216,422 $16.5 Million
Q1 2025 May 15, 2025	SELL	$67.38 - $88.96 $17.7 Million - $23.3 Million	-262,206 Reduced 33.05%	531,210 $37.7 Million
Q4 2024 Feb 14, 2025	SELL	$77.87 - $104.93 $5.49 Million - $7.4 Million	-70,541 Reduced 8.16%	793,416 $62.1 Million
Q3 2024 Nov 14, 2024	BUY	$67.44 - $112.17 $11.3 Million - $18.8 Million	167,350 Added 24.02%	863,957 $88.4 Million
Q2 2024 Aug 14, 2024	BUY	$62.76 - $81.61 $1.49 Million - $1.94 Million	23,730 Added 3.53%	696,607 $52.8 Million
Q1 2024 May 15, 2024	SELL	$72.35 - $88.99 $19.2 Million - $23.6 Million	-264,851 Reduced 28.24%	672,877 $50.5 Million
Q4 2023 Feb 14, 2024	SELL	$42.42 - $80.28 $12.8 Million - $24.2 Million	-301,675 Reduced 24.34%	937,728 $69 Million
Q3 2023 Nov 14, 2023	SELL	$39.12 - $49.85 $7.88 Million - $10 Million	-201,327 Reduced 13.97%	1,239,403 $57 Million
Q2 2023 Aug 14, 2023	BUY	$23.58 - $44.68 $900,873 - $1.71 Million	38,205 Added 2.72%	1,440,730 $60.8 Million
Q1 2023 May 15, 2023	SELL	$25.42 - $33.52 $6.88 Million - $9.07 Million	-270,689 Reduced 16.18%	1,402,525 $36.6 Million
Q4 2022 Feb 14, 2023	BUY	$18.46 - $36.37 $1.79 Million - $3.52 Million	96,888 Added 6.15%	1,673,214 $49.8 Million
Q3 2022 Nov 14, 2022	BUY	$13.55 - $19.92 $2.36 Million - $3.46 Million	173,875 Added 12.4%	1,576,326 $30.6 Million
Q2 2022 Aug 15, 2022	BUY	$7.4 - $15.07 $1.79 Million - $3.65 Million	242,383 Added 20.89%	1,402,451 $19 Million
Q1 2022 May 16, 2022	SELL	$11.65 - $19.57 $240,316 - $403,689	-20,628 Reduced 1.75%	1,160,068 $16.1 Million
Q4 2021 Feb 14, 2022	BUY	$18.01 - $30.1 $2.31 Million - $3.86 Million	128,302 Added 12.19%	1,180,696 $22.5 Million
Q3 2021 Nov 15, 2021	BUY	$18.25 - $38.35 $19.2 Million - $40.4 Million	1,052,394 New	1,052,394 $23.7 Million

Others Institutions Holding NUVL

# of Institutions

225

Shares Held

59.8M

Call Options Held

191K

Put Options Held

306K

View Full List

About Nuvalent, Inc.

Ticker NUVL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,977,800
Market Cap $3.6B
Description
Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...

More about NUVL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.

Account

Driehaus Capital Management LLC Nuvalent, Inc. Transaction History